Claris Lifesciences Ltd

Claris Lifescien Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Claris Lifesciences Ltd

₹ 397 -0.06%
14 Mar 2018
clarislifesciences.com BSE: 533288
About

Claris Lifesciences Limited is engaged in manufacturing of drugs and pharmaceutical products.

[ add key points ]
Website BSE
  • Market Cap ₹ 2,164 Cr.
  • Current Price ₹ 397
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -1.17
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2014 Mar 2015 Jun 2015 Sep 2015 Dec 2015 Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017
183 158 187 197 26 18 1 2 5 3 3 4 2
136 134 141 184 65 39 16 27 39 21 22 16 375
Operating Profit 47 24 46 13 -40 -21 -15 -25 -34 -19 -19 -11 -373
OPM % 26% 15% 25% 6% -155% -114% -1,104% -1,411% -752% -676% -611% -264% -18,034%
27 14 8 21 33 17 40 56 44 53 38 1,865 59
Interest 11 10 10 11 1 2 1 4 1 1 1 1 1
Depreciation 9 9 10 4 1 1 2 -0 1 2 1 1 1
Profit before tax 53 18 34 18 -8 -7 22 27 8 32 17 1,852 -316
Tax % -70% 30% 37% 24% -276% -91% 1% -20% -121% -17% -16% 1% 1%
90 10 19 12 -70 -1 22 32 19 37 19 1,840 -317
EPS in Rs 16.47 1.91 3.53 2.20 -12.84 -0.11 4.03 5.94 3.40 6.77 3.52 337.24 -58.17
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 15m Mar 2016 Mar 2017 Mar 2018 Mar 2019
597.15 752.16 743.52 752.34 740.49 767.36 667.76 799.76 133.16 0.00 0.00 0.00
461.84 553.82 510.97 514.86 494.25 502.55 521.49 661.69 267.16 10.64 25.19 12.47
Operating Profit 135.31 198.34 232.55 237.48 246.24 264.81 146.27 138.07 -134.00 -10.64 -25.19 -12.47
OPM % 22.66% 26.37% 31.28% 31.57% 33.25% 34.51% 21.90% 17.26% -100.63%
26.64 12.78 9.23 16.46 15.33 10.29 78.76 103.71 80.99 120.14 42.57 7.63
Interest 15.47 32.24 53.26 46.75 55.43 65.05 52.19 48.26 5.48 0.00 0.00 0.00
Depreciation 26.81 36.60 44.81 46.72 54.68 74.27 65.35 49.05 3.86 0.14 0.10 0.00
Profit before tax 119.67 142.28 143.71 160.47 151.46 135.78 107.49 144.47 -62.35 109.36 17.28 -4.84
Tax % 30.42% 23.82% 9.28% 11.86% 16.64% 23.47% 20.54% -8.45% -36.74% -0.51% 9.90% 54.75%
83.27 108.39 130.37 141.44 126.25 103.91 84.41 149.48 -39.44 109.93 15.56 -7.49
EPS in Rs 22.16 19.78 16.28 13.23 27.39 -7.23 20.15 3.12 -1.37
Dividend Payout % 10.58% 2.17% 7.85% 9.02% 10.11% 12.28% 68.05% 0.00% -27.67% 9.93% 64.20% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -190%
Stock Price CAGR
10 Years: 5%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity Capital 29.36 29.36 34.12 63.82 63.82 63.82 63.82 54.57 54.57 54.57 54.57 54.57
Reserves 208.97 312.70 476.08 851.17 988.29 1,085.05 1,340.48 1,262.14 864.94 965.37 -53.86 -60.94
285.97 391.15 314.01 360.63 408.64 542.09 267.78 533.82 598.73 21.56 0.00 0.00
275.40 309.86 531.62 418.91 269.86 311.34 438.84 333.25 229.06 740.65 23.31 28.10
Total Liabilities 799.70 1,043.07 1,355.83 1,694.53 1,730.61 2,002.30 2,110.92 2,183.78 1,747.30 1,782.15 24.02 21.73
301.85 494.55 492.03 530.60 663.27 870.60 571.57 1,074.29 866.17 56.41 0.00 0.00
CWIP 112.41 73.54 123.23 233.57 41.92 174.27 173.29 2.83 10.42 2.40 0.00 0.00
Investments 0.02 0.02 0.02 0.02 0.02 0.02 818.32 533.92 308.28 291.26 0.00 0.00
385.42 474.96 740.55 930.34 1,025.40 957.41 547.74 572.74 562.43 1,432.08 24.02 21.73
Total Assets 799.70 1,043.07 1,355.83 1,694.53 1,730.61 2,002.30 2,110.92 2,183.78 1,747.30 1,782.15 24.02 21.73

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
49.25 136.24 380.80 69.67 -18.93 334.18 143.38 -41.43 20.46 179.35 -5.82 -0.15
-139.35 -201.82 -103.81 -191.86 -221.22 -436.61 197.01 -122.86 56.80 -58.46 -133.48 0.35
28.10 67.38 -56.95 280.86 -24.20 58.27 -342.88 152.21 22.28 -105.49 -13.14 0.00
Net Cash Flow -62.00 1.80 220.04 158.67 -264.35 -44.16 -2.49 -12.07 99.54 15.41 -152.44 0.21

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Dec 2007 Dec 2008 Dec 2009 Dec 2010 Dec 2011 Dec 2012 Dec 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Debtor Days 151.96 131.43 129.98 119.54 135.04 108.56 85.55 104.58 458.91
Inventory Days 144.24 152.01 202.51 236.25 227.47 268.54 66.44 96.51 337.48
Days Payable 168.87 134.31 268.75 207.26 107.34 156.09 110.97 130.52 518.84
Cash Conversion Cycle 127.33 149.13 63.74 148.52 255.17 221.01 41.02 70.57 277.55
Working Capital Days 77.26 97.00 11.65 81.48 199.37 152.54 -62.96 71.29 336.30
ROCE % 29.72% 27.76% 26.23% 19.78% 15.17% 12.74% 8.29% 9.95% -1.23% 8.54% 1.92%

Shareholding Pattern

Numbers in percentages

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017
60.99% 52.56% 50.13% 50.13% 50.13% 50.13% 50.13%
20.29% 25.43% 25.86% 26.48% 26.22% 25.62% 26.02%
1.35% 1.35% 1.49% 1.86% 1.86% 1.94% 1.94%
17.36% 20.66% 22.52% 21.53% 21.79% 22.31% 21.91%
No. of Shareholders 20,98320,54920,11719,65918,19817,90217,032

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings